Fibrocalculous Pancreatic Diabetes: Changing Clinical Spectrum and Glycaemic Response to Pioglitazone
Don David, Manjunath Goroshi, Vanishri Ganakumar, Vikrant Ghatnatti · 2026
Read Fibrocalculous Pancreatic Diabetes: Changing Clinical Spectrum and Glycaemic Response to Pioglitazone by Don David, Manjunath Goroshi, Vanishri Ganakumar, Vikrant Ghatnatti (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13427006.txt.
Description
David, Goroshi, Ganakumar, and Ghatnatti review patients with fibrocalculous pancreatic diabetes, a form of diabetes caused by a scarred, stone-filled pancreas, in a 2026 study from North Karnataka. The classic picture of the disease is changing: patients now present older and with normal weight more often.
Average age at diagnosis was forty-two, after a delay of nearly three years, and only about one in ten was diagnosed correctly at first. Despite insulin, most kept losing weight and suffered frequent low blood sugar episodes. Adding pioglitazone beat metformin at improving control and cutting insulin needs, which the authors link to its action on liver insulin resistance.
Catalog record
| CREATOR | Don David, Manjunath Goroshi, Vanishri Ganakumar, Vikrant Ghatnatti |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 18 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |